Heart Failure: Stopping Medication After Cardiac Resynchronization Therapy

We are studying the effects of withdrawing medication in patients who have improved heart function after cardiac resynchronization therapy. This trial will help us understand the safety and changes in heart health when treatment is stopped.

>2 yearsMonitoring phase (IV)No PlaceboInvestigational MedicinesOralCardiologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Bisoprolol Cor Viatris
Bisoprolol Cor Viatris is a medicine used to treat high blood pressure and heart conditions by helping the heart beat more slowly and steadily.
Bisoprolol Fumarate
Bisoprolol Fumarate is a medicine used to treat high blood pressure and some heart conditions by slowing the heart and reducing its workload.
Diován Cardio
Diován Cardio is a medicine used to lower high blood pressure and help manage certain heart conditions.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Bisoprolol
Bisoprolol is a substance that helps lower high blood pressure and reduces strain on the heart.
Bisoprolol Fumarate
Bisoprolol fumarate is a substance that helps lower high blood pressure and reduce strain on the heart.
Eplerenone
Eplerenone is a substance that lowers blood pressure and reduces fluid buildup to protect and improve heart function after heart failure or attack.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Diován

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Acebis
Acebis
Aldepla

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hospital Universitari Germans Trias I Pujol
Cardiology Department
Badalona, Spain
University Clinical Hospital Virgen De La Arrixaca
Cardiology Department
Fuente-Álamo de Murcia, Spain
Hospital Universitario Severo Ochoa
Cardiología
Leganés, Spain
Sponsor: Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.